Clinical Trials Browser

Prostatic Neoplasms × strontium chloride × Clear all

NCT00365105 2024-09-20

Zoledronate, Vitamin D, and Calcium With or Without Strontium 89 or Samarium 153 in Preventing or Delaying Bone Problems in Patients With Bone Metastases From Prostate Cancer, Lung Cancer, or Breast Cancer

Phase 3 Completed

261 enrolled 12 charts

BreastGenitourinaryThoracic

Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Neoplasm Metastasis, Pain, Prostatic Neoplasms

NCT00080782 2018-10-31

Doxorubicin and Strontium-89 With or Without Celecoxib in Treating Patients With Progressive Androgen-Independent Prostate Cancer and Bone Metastases

Phase 2 Terminated

Neoplasm Metastasis, Prostatic Neoplasms

NCT00081159 2016-11-10

Hormone Ablation Therapy, Doxorubicin, and Zoledronate With or Without Strontium 89 in Treating Patients With Androgen-Dependent Prostate Cancer and Bone Metastases

Phase 2 Completed

80 enrolled 6 charts

Neoplasm Metastasis, Prostatic Neoplasms

NCT00024167 2016-03-22

Chemotherapy With or Without Strontium-89 in Treating Patients With Prostate Cancer

Phase 3 Terminated

265 enrolled 9 charts

Prostatic Neoplasms

NCT00554918 2013-08-07

Docetaxel and Prednisolone With or Without Zoledronic Acid and/or Strontium Chloride Sr 89 in Treating Patients With Prostate Cancer Metastatic to Bone That Has Not Responded to Hormone Therapy

Phase 2 Completed

Neoplasm Metastasis, Prostatic Neoplasms

NCT00002503 2012-09-24

Strontium Compared With Radiation Therapy in Treating Patients With Hormone-Refractory Prostate Cancer With Painful Bone Metastases

Phase 3 Completed

Neoplasm Metastasis, Prostatic Neoplasms